BioLife Solutions

PanThera CryoSolutions designs and manufactures cryopreservation solutions and systems to preserve cells, tissues, and small molecules used in clinical research. The company develops patented ice recrystallization inhibitors that minimize ice crystal formation during freezing, enabling less costly storage and transportation methods and reducing reliance on liquid nitrogen in certain cell therapies. Its products aim to maintain cellular function after extended frozen storage, reduce toxicity, enhance stability, and improve post-thaw performance, helping researchers and clinicians preserve biological material more efficiently. Through scientific expertise, PanThera CryoSolutions supports reliable, scalable cryopreservation that underpins medical research, drug development, and therapeutic applications by enabling safer and more economical cryogenic storage.

iVexSol specializes in developing and manufacturing lentiviral vectors (LVVs), which serve as critical gene delivery vehicles for cell and gene therapies. Founded in 2018, the company is headquartered in Worcester, Massachusetts. iVexSol's innovative technology addresses the shortage of LVVs by producing them in greater quantities and at a lower cost than traditional methods. This enables shorter clinical development timelines, increased access to life-saving treatments for patients worldwide.

Sexton Biotechnologies is a biotechnology company founded in 2019 and based in Indianapolis, Indiana. It specializes in developing and selling bioproduction tools specifically designed for cell and gene therapy. The company focuses on creating tools and media that facilitate flexible automation and scaling in cell manufacturing processes, ultimately aiming to enhance clinical outcomes. Sexton Biotechnologies is recognized for its innovative container closure and media supplementation solutions, which are essential for the bioproduction of cell and gene therapies. Through ongoing research and product development, the company seeks to expand its market presence and commercialize its offerings effectively.

Stirling Ultracold develops and manufactures ultra-low temperature freezers operating below -86°C. Its patented free-piston Stirling engine technology enables energy-efficient, environmentally friendly storage for bio-repositories and pharmaceutical companies.

PanThera CryoSolutions designs and manufactures cryopreservation solutions and systems to preserve cells, tissues, and small molecules used in clinical research. The company develops patented ice recrystallization inhibitors that minimize ice crystal formation during freezing, enabling less costly storage and transportation methods and reducing reliance on liquid nitrogen in certain cell therapies. Its products aim to maintain cellular function after extended frozen storage, reduce toxicity, enhance stability, and improve post-thaw performance, helping researchers and clinicians preserve biological material more efficiently. Through scientific expertise, PanThera CryoSolutions supports reliable, scalable cryopreservation that underpins medical research, drug development, and therapeutic applications by enabling safer and more economical cryogenic storage.

iVexSol specializes in developing and manufacturing lentiviral vectors (LVVs), which serve as critical gene delivery vehicles for cell and gene therapies. Founded in 2018, the company is headquartered in Worcester, Massachusetts. iVexSol's innovative technology addresses the shortage of LVVs by producing them in greater quantities and at a lower cost than traditional methods. This enables shorter clinical development timelines, increased access to life-saving treatments for patients worldwide.

iVexSol specializes in developing and manufacturing lentiviral vectors (LVVs), which serve as critical gene delivery vehicles for cell and gene therapies. Founded in 2018, the company is headquartered in Worcester, Massachusetts. iVexSol's innovative technology addresses the shortage of LVVs by producing them in greater quantities and at a lower cost than traditional methods. This enables shorter clinical development timelines, increased access to life-saving treatments for patients worldwide.

Sexton Biotechnologies is a biotechnology company founded in 2019 and based in Indianapolis, Indiana. It specializes in developing and selling bioproduction tools specifically designed for cell and gene therapy. The company focuses on creating tools and media that facilitate flexible automation and scaling in cell manufacturing processes, ultimately aiming to enhance clinical outcomes. Sexton Biotechnologies is recognized for its innovative container closure and media supplementation solutions, which are essential for the bioproduction of cell and gene therapies. Through ongoing research and product development, the company seeks to expand its market presence and commercialize its offerings effectively.

Savsu Technologies specializes in creating hardware and software solutions aimed at safeguarding live cell therapies during transportation and storage. Their products include cloud-connected storage and transport containers equipped with integrated sensors and communication systems, ensuring thermal stability for temperature-sensitive biotech and pharmacological materials. The company serves a diverse range of clients, including cell and gene therapy companies, specialty couriers, biotech/biopharma firms, research institutions, governments, and NGOs. Savsu's mission is to enhance the safe and effective delivery of these critical materials, thereby reducing costs and improving outcomes for their clients.

Savsu Technologies specializes in creating hardware and software solutions aimed at safeguarding live cell therapies during transportation and storage. Their products include cloud-connected storage and transport containers equipped with integrated sensors and communication systems, ensuring thermal stability for temperature-sensitive biotech and pharmacological materials. The company serves a diverse range of clients, including cell and gene therapy companies, specialty couriers, biotech/biopharma firms, research institutions, governments, and NGOs. Savsu's mission is to enhance the safe and effective delivery of these critical materials, thereby reducing costs and improving outcomes for their clients.

Savsu Technologies specializes in creating hardware and software solutions aimed at safeguarding live cell therapies during transportation and storage. Their products include cloud-connected storage and transport containers equipped with integrated sensors and communication systems, ensuring thermal stability for temperature-sensitive biotech and pharmacological materials. The company serves a diverse range of clients, including cell and gene therapy companies, specialty couriers, biotech/biopharma firms, research institutions, governments, and NGOs. Savsu's mission is to enhance the safe and effective delivery of these critical materials, thereby reducing costs and improving outcomes for their clients.